Literature DB >> 19164446

Interruption of growth hormone signaling via SHC and ERK in 3T3-F442A preadipocytes upon knockdown of insulin receptor substrate-1.

Xiangdong Wang1, Ning Yang, Luqin Deng, Xin Li, Jing Jiang, Yujun Gan, Stuart J Frank.   

Abstract

Insulin receptor substrate-1 (IRS-1) is a docking protein tyrosine phosphorylated in response to insulin, IGF-1, GH, and other cytokines. IRS-1 has an N-terminal plekstrin homology domain (which facilitates membrane localization), a phosphotyrosine-binding domain [which associates with tyrosine-phosphorylated insulin receptor or IGF-1 receptor (IGF-1R)], and tyrosine residues that, when phosphorylated, bind signaling molecules. The role of IRS-1 in GH signaling is uncertain. We previously reported that IRS-1 and Janus kinase 2 associate independently of tyrosine phosphorylation via IRS-1's N terminus and that IRS-1 reconstitution greatly enhances GH-induced ERK, but not STAT5, activation. We now use GH-responsive 3T3-F442A preadipocytes to study the influence of IRS-1 on GH action. We stably transfected cells with vector only (Control) or a vector encoding IRS-1 short hairpin RNA [knockdown (KD)] and compared representative clones. Immunoblotting confirmed more than 80% knockdown of IRS-1 in KD cells. GH caused characteristic Janus kinase 2 and STAT5 activation in both Control and KD cells, but ERK activation was dramatically reduced in KD cells in GH time course and dose-response experiments. Notably, GH-induced Src homology collagen (SHC) activation and SHC-Grb2 association in KD cells were also markedly diminished compared with Control cells. Subcellular fractionation revealed that IRS-1 in Control cells was largely cytosolic, but the component isolated with plasma membranes was highly enriched in lipid raft membranes (LR). In KD cells, GH-induced ERK activation in the LR fraction was particularly diminished compared with Control cells. These data suggest that LR-enriched IRS-1 contributes substantially to GH-induced ERK activation in LR in 3T3-F442A fibroblasts. Furthermore, our results are consistent with IRS-1 residing upstream of SHC in the GH-induced ERK-signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19164446      PMCID: PMC2667707          DOI: 10.1210/me.2008-0407

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  84 in total

1.  Activation of growth hormone receptor delivers an antiapoptotic signal: evidence for a role of Akt in this pathway.

Authors:  J A Costoya; J Finidori; S Moutoussamy; R Seãris; J Devesa; V M Arce
Journal:  Endocrinology       Date:  1999-12       Impact factor: 4.736

2.  Growth hormone-induced alteration in ErbB-2 phosphorylation status in 3T3-F442A fibroblasts.

Authors:  S O Kim; J C Houtman; J Jiang; J M Ruppert; P J Bertics; S J Frank
Journal:  J Biol Chem       Date:  1999-12-10       Impact factor: 5.157

3.  Disulfide linkage of growth hormone (GH) receptors (GHR) reflects GH-induced GHR dimerization. Association of JAK2 with the GHR is enhanced by receptor dimerization.

Authors:  Y Zhang; J Jiang; J J Kopchick; S J Frank
Journal:  J Biol Chem       Date:  1999-11-12       Impact factor: 5.157

4.  Role of the growth hormone (GH) receptor transmembrane domain in receptor predimerization and GH-induced activation.

Authors:  Ning Yang; Xiangdong Wang; Jing Jiang; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2007-04-24

5.  Insulin-like growth factor-I activation of Akt survival cascade in neuronal cells requires the presence of its cognate receptor in caveolae.

Authors:  Xiuli Lu; Fukushi Kambe; Xia Cao; Masako Yamauchi; Hisao Seo
Journal:  Exp Cell Res       Date:  2007-10-26       Impact factor: 3.905

6.  Activation of growth hormone receptors by growth hormone and growth hormone antagonist dimers: insights into receptor triggering.

Authors:  Ning Yang; John F Langenheim; Xiangdong Wang; Jing Jiang; Wen Y Chen; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2007-12-20

Review 7.  Growth hormone regulation of sex-dependent liver gene expression.

Authors:  David J Waxman; Caitlin O'Connor
Journal:  Mol Endocrinol       Date:  2006-03-16

8.  JAK2, but not Src family kinases, is required for STAT, ERK, and Akt signaling in response to growth hormone in preadipocytes and hepatoma cells.

Authors:  Hui Jin; Nathan J Lanning; Christin Carter-Su
Journal:  Mol Endocrinol       Date:  2008-05-22

9.  An agonist-induced conformational change in the growth hormone receptor determines the choice of signalling pathway.

Authors:  Scott W Rowlinson; Hideo Yoshizato; Johanna L Barclay; Andrew J Brooks; Stuart N Behncken; Linda M Kerr; Kirstin Millard; Kathryn Palethorpe; Katherine Nielsen; Jodie Clyde-Smith; John F Hancock; Michael J Waters
Journal:  Nat Cell Biol       Date:  2008-05-18       Impact factor: 28.824

Review 10.  New insights into growth hormone action.

Authors:  M J Waters; H N Hoang; D P Fairlie; R A Pelekanos; R J Brown
Journal:  J Mol Endocrinol       Date:  2006-02       Impact factor: 5.098

View more
  7 in total

1.  Synergy in ERK activation by cytokine receptors and tyrosine kinase growth factor receptors.

Authors:  Xin Li; Yao Huang; Jing Jiang; Stuart J Frank
Journal:  Cell Signal       Date:  2010-10-11       Impact factor: 4.315

2.  Functional collaboration of insulin-like growth factor-1 receptor (IGF-1R), but not insulin receptor (IR), with acute GH signaling in mouse calvarial cells.

Authors:  Yujun Gan; Andrew J Paterson; Yue Zhang; Jing Jiang; Stuart J Frank
Journal:  Endocrinology       Date:  2013-01-01       Impact factor: 4.736

3.  The intricate role of growth hormone in metabolism.

Authors:  Archana Vijayakumar; Shoshana Yakar; Derek Leroith
Journal:  Front Endocrinol (Lausanne)       Date:  2011-09-27       Impact factor: 5.555

4.  Intracellular signaling transduction pathways triggered by a well-known anti-GHR monoclonal antibody, Mab263, in vitro and in vivo.

Authors:  Hainan Lan; Wei Li; Hailong Jiang; Yanhong Yang; Xin Zheng
Journal:  Int J Mol Sci       Date:  2014-11-10       Impact factor: 5.923

Review 5.  Classical and novel GH receptor signaling pathways.

Authors:  Stuart J Frank
Journal:  Mol Cell Endocrinol       Date:  2020-08-22       Impact factor: 4.102

6.  Effects of insulin and IGF-I on growth hormone- induced STAT5 activation in 3T3-F442A adipocytes.

Authors:  Yuchao Zhang; Yuantao Liu; Xia Li; Weina Gao; Wenjie Zhang; Qingbo Guan; Jing Jiang; Stuart J Frank; Xiangdong Wang
Journal:  Lipids Health Dis       Date:  2013-04-30       Impact factor: 3.876

7.  Research resource: identification of novel growth hormone-regulated phosphorylation sites by quantitative phosphoproteomics.

Authors:  Bridgette N Ray; Hye Kyong Kweon; Lawrence S Argetsinger; Diane C Fingar; Philip C Andrews; Christin Carter-Su
Journal:  Mol Endocrinol       Date:  2012-05-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.